Literature DB >> 8517328

Determining the volume of prostatic carcinoma: value of MR imaging with an external-array coil.

F G Sommer1, H V Nghiem, R Herfkens, J McNeal, R N Low.   

Abstract

OBJECTIVE: The size of prostatic carcinomas, as determined by estimations of the tumor volume, has a direct correlation with the histologic grade and stage. Therefore, accurate information about tumor volume can play an important role in determining appropriate treatment and establishing a patient's prognosis. Accordingly, we performed a study to assess the accuracy of MR imaging with external-array coils and the fast spin-echo technique for determining tumor volume in patients with prostatic cancer. SUBJECTS AND METHODS: In a prospective study, 20 patients with biopsy-proved prostatic cancer had MR imaging before radical prostatectomy. A 1.5-T system, a prototype external-array coil, and fast spin-echo technique were used to obtain axial T2-weighted (4000/120 [TR/TE]) MR images throughout the prostate and seminal vesicles. Contiguous 5-mm sections were obtained with a 256 x 256 or 256 x 192 matrix, 24-cm field of view, four excitations, and fat suppression. The volumes of cancer obtained with MR imaging and surgical specimens were determined independently. The areas of tumor were determined from individual axial sections by summing and multiplying by the section thickness.
RESULTS: Seventeen of the 20 cancers were detected on MR images. A significant correlation between the volume of the tumor as determined with MR imaging and measurements of the specimens was observed (r = .81, p < .001). Four transition zone tumors were detected as zones of rather homogeneous decreased intensity. One important source of error for volumes determined with MR images was a limitation in the histologic specificity of MR imaging for the delineation of cancer; in some cases benign changes or normal prostates were interpreted as cancer. Another limitation was the presence of changes after biopsy that concealed portions of 10 of the 17 tumors visualized.
CONCLUSION: The accuracy of the MR technique used was not sufficient for reliable prediction of tumor volume. The lack of specificity of T2-weighted MR imaging for cancer detection and the presence of changes caused by biopsy were major sources of error.

Entities:  

Mesh:

Year:  1993        PMID: 8517328     DOI: 10.2214/ajr.161.1.8517328

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  15 in total

Review 1.  Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer.

Authors:  J Kurhanewicz; D B Vigneron; S J Nelson
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

Review 2.  Methods for volume assessment of prostate cancer.

Authors:  Heinz-Peter Schlemmer; Stefan Corvin
Journal:  Eur Radiol       Date:  2004-02-06       Impact factor: 5.315

Review 3.  Primary staging of prostate cancer.

Authors:  G J Jager; J O Barentz; E T Ruijter; J J de la Rosette; G O Oosterhof
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

4.  Symmetry based prostate cancer detection.

Authors:  L Yang; Y Xie; B Li; M Xie; X Wang; J Zhang
Journal:  Br J Radiol       Date:  2015-04-22       Impact factor: 3.039

5.  The predictability of T3 disease in staging MRI following prostate biopsy decreases in patients with high initial PSA and Gleason score.

Authors:  Young Hwii Ko; Deuk Jae Sung; Sung Gu Kang; Seok Ho Kang; Jeong Gu Lee; Je Jong Kim; Jun Cheon
Journal:  Asian J Androl       Date:  2011-03-07       Impact factor: 3.285

6.  The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel.

Authors:  Berrend G Muller; Jurgen J Fütterer; Rajan T Gupta; Aaron Katz; Alexander Kirkham; John Kurhanewicz; Judd W Moul; Peter A Pinto; Ardeshir R Rastinehad; Cary Robertson; Jean de la Rosette; Rafael Sanchez-Salas; J Stephen Jones; Osamu Ukimura; Sadhna Verma; Hessel Wijkstra; Michael Marberger
Journal:  BJU Int       Date:  2013-11-13       Impact factor: 5.588

Review 7.  Focal ablation of prostate cancer: four roles for magnetic resonance imaging guidance.

Authors:  Graham Sommer; Donna Bouley; Harcharan Gill; Bruce Daniel; Kim Butts Pauly; Chris Diederich
Journal:  Can J Urol       Date:  2013-04       Impact factor: 1.344

8.  MR-guided transgluteal biopsies with an open low-field system in patients with clinically suspected prostate cancer: technique and preliminary results.

Authors:  Stephan Zangos; Katrin Eichler; Kerstin Engelmann; Mukhtiar Ahmed; Sebastian Dettmer; Christopher Herzog; Wasilios Pegios; A Wetter; Thomas Lehnert; Martin G Mack; Thomas J Vogl
Journal:  Eur Radiol       Date:  2004-09-04       Impact factor: 5.315

9.  Prostate tumor volume measurement with combined T2-weighted imaging and diffusion-weighted MR: correlation with pathologic tumor volume.

Authors:  Yousef Mazaheri; Hedvig Hricak; Samson W Fine; Oguz Akin; Amita Shukla-Dave; Nicole M Ishill; Chaya S Moskowitz; Joanna E Grater; Victor E Reuter; Kristen L Zakian; Karim A Touijer; Jason A Koutcher
Journal:  Radiology       Date:  2009-08       Impact factor: 11.105

Review 10.  Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer.

Authors:  John Kurhanewicz; Mark G Swanson; Sarah J Nelson; Daniel B Vigneron
Journal:  J Magn Reson Imaging       Date:  2002-10       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.